SP TRIO D FORTE TABLET

Product Description

Product Name: SP TRIO D FORTE TABLETComposition: Sitagliptin 100mg + Dapagliflozin 10mg + Metformin 1000mg (ER)Product Description for Trade India & B2B Platforms: SP TRIO D FORTE TABLET is a powerful triple-combination therapy formulated with Sitagliptin 100mg, Dapagliflozin 10mg, and Metformin 1000mg (Extended Release) for advanced management of Type 2 Diabetes Mellitus. Designed for patients requiring comprehensive glycemic control, this high-strength formulation offers multi-mechanism efficacy in a single convenient dose. Ideal for pharmaceutical distributors, bulk buyers, and retailers, SP TRIO D FORTE meets growing demand in the diabetic care segment.Key Benefits: Triple-Action Therapy: Sitagliptin enhances insulin secretion (DPP-4 inhibitor)Dapagliflozin promotes glucose excretion via kidneys (SGLT2 inhibitor)Metformin (ER) improves insulin sensitivity and reduces hepatic glucose output Effective HbA1c Reduction: Targets fasting and postprandial blood sugar levels. Extended Release Metformin: Ensures better GI tolerance and sustained effect. Cardio-Renal Benefits: Dapagliflozin supports cardiovascular and renal protection. Usage/Application: Indicated for adults with Type 2 Diabetes Mellitus not adequately controlled with dual therapy. Typically prescribed for long-term diabetes management under medical supervision. Administered once daily with meals to optimize effectiveness and tolerability. Why Choose SP TRIO D FORTE: High-potency triple therapy in one tablet for better patient compliance. Manufactured in WHO-GMP certified facilities for global quality standards. Available in bulk quantities, ideal for hospital supply, large pharmacies, and B2B distribution. Private labeling and custom packaging options available